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1. Introduction
This book, as its title indicates, is about “Serotonin: a chemical messenger for all living cells”, 
which is not only present in every tissue of human body but also detected in all aerobic organ-
ism including plant and bacteria. In humans, serotonin acts as a trophic factor starts soon after 
conception and is directly related to the production of serotonin by mother’s enterochromaf-
fin cells in the gut and its transfer into the platelets in mother’s blood. At the same time from a 
very early stage of gestation, fetus also starts synthesizing its own serotonin in a special group 
of nuclei of the midbrain. Soon after serotonergic neurons distribute it throughout the brain 
and body of the fetus in turn increases division, migration and maturation of both central and 
peripheral tissues.
Serotonin, which is also known as 5-hydroxytryptamine (5-HT), acts both as neurotransmitter 
and hormone and is mainly found in the brain, bowels and blood platelets. In 1948, Rapport 
identified a serum agent that affected vascular tone and called it serotonin. Later, in 1950, he 
identified chemical composition of serotonin and named it 5-hydroxytryptamine. Serotonin, 
a biogenic amine is produced by the conversion of amino acid tryptophan in the presence of 
an enzyme tryptophan hydroxylase (TPH) that exists both in brain and bowel. Till now this 
enzyme is of two types: TPH1 (found in peripheral organs and CNS) and TPH2 (present only 
in the brain).
Enteroendocrine cells derived 5-HT acts also as a hormone, which perform multiple func-
tions including inhibition of osteoblast proliferation and promotion of hepatic regeneration. 
The chemical formula of 5-HT is N
2
OC10H12, such that 15.8970% nitrogen, 9.0793% oxygen, 68.1598% carbon and 6.8638% hydrogen.
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2. Effect of serotonin on brain and body
In the central nervous system, serotonin is synthesized by the neurons of the Raphe nuclei 
from the amino acid tryptophan through a short metabolic pathway that contains two 
enzymes: tryptophan hydroxylase and amino acid decarboxylase, and is distributed along 
the length of the brainstem. Serotonin is released from the varicosities along the axon into 
the extra-neuronal space this provides a larger area for serotonin to activate its receptors that 
exist on the dendrites, the cell bodies and the presynaptic terminals of the adjacent neurons. 
Thus serotonin not only stimulates postsynaptic serotonin receptors but also present on the 
extrasynaptic neurons.
Thus, it is not a surprise to find significant role of serotonin in the modulation of many behav-
ioral and psychotic disorders such as mood, sleep, appetite, vomiting, sexuality, memory, 
learning, temperature, cardiovascular and endocrine regulation.
Both high and low levels of serotonin have harmful effect. High serotonin levels cause severe 
toxicity termed as “serotonin syndrome”, which can be fatal in some cases, whereas low lev-
els of serotonin have been associated with migraines, bipolar disorders, apathy, fear, feel-
ings of worthlessness, insomnia, fatigue, anxiety and depression. These pathologies may be 
explained by the fact that 10% of large dorsal raphe nuclei (largest source of serotonin synthe-
sis) are projected to amygdala and other medium raphe nuclei project to caudate, putamen 
and olfactory bulb. It is important to mention here that serotonin is required for the metabo-
lism of stress hormone.
Scientific evidence confirms that genetic polymorphisms in the enzyme tryptophan hydroxy-
lase in both TPH1 and TPH2 forms can affect the susceptibility to depression and anxiety. 
Furthermore, ovarian hormones can affect the expression of tryptophan hydroxylase, trig-
gering postnatal depression and premenstrual stress syndrome, and expression of abnormal 
serotonergic neurons in infants may lead to high possibility of having sudden infant death 
syndrome (SIDS). Serotonin is also involved in the regeneration of organs such as liver and 
bone and induces cell division throughout the body.
Large diversity of serotonin receptors creates its pharmacological complexity. There are at 
least seven types and eight subtypes of serotonin receptors that have been identified in differ-
ent areas of the body, and they all have diverse effects. Serotonin receptors are activated by 
psychoactive drugs such as ecstasy (MDMA), LSD, DMT and psilocybin (a substance found 
in psychedelic mushrooms). A small dose of ecstasy, for example, stimulates a big release of 
serotonin in the body causing feelings of well-being and comfort but with many side effects.
5-HT receptors (1–7) are mainly second messenger-gated receptors of which only serotonin 
type-3 receptor is Ligand-gated ion channel and is involved in nausea and emesis as well 
as a therapeutic target for depression and other mental conditions. 5-HT1 receptor has five 
subtypes (5-HT1A–1F, no 1E subtype) which are potential site for anxiolytics and antidepres-
sants as these receptors are mainly responsible for regulating emotions and proprioception. 
Activation of 5-HT1B and 1D receptors cause vasoconstriction and their antagonists are used 
for the treatment of schizophrenia and migraines and their partial agonist acts as therapeutic 
targets for anxiety and depression.
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Similarly, 5-HT2 receptor has three subtypes (5-HT2A–2C) and responsible for sleep, pain 
and motor regulation and are targeted for conditions such as anxiety, migraine and eating 
disorders. There are certain psychiatric medications that modulate the levels of serotonin 
in the human body. These drugs are classified into four general categories: (1) monoamine 
 oxidase inhibitors (MAO), (2) tricyclic (TCA) antidepressants, (3) atypical antipsychotics and 
(4) selective serotonin reuptake inhibitors (SSRIs). SSRIs are prescribed for the treatment of 
social phobia, anxiety disorders, panic disorders, obsessive-compulsive disorders (OCD), 
major depression, irritable bowel syndrome (IBS) and eating disorders.
It is vital to know the mechanism of neuronal communication to understand the mode of 
action of SSRIs. Briefly, two neurons talk to each other by releasing their neurotransmitters in 
a space (known as synapse) between them. These neurotransmitters travel from presynaptic 
neurons via synapse to their specific receptors present on the postsynaptic neurons and stim-
ulate them. Once the postsynaptic neurons receive this signal and get activated, these neu-
rotransmitters go back through the transporters present on the presynaptic neurons. SSRIs are 
the class of drugs that inhibit these serotonin transporter’s activities and let serotonin to halt 
in synapse for a longer period of time. Whereas TCA will let both serotonin and norepineph-
rine to stay in the gap for extended period of time than normal so both types of postsynaptic 
neurons can stimulate completely.
As mentioned earlier, all neurotransmitters, especially biogenic amines (serotonin, norepi-
nephrine and dopamine) regulate each other, for example, stimulating 5-HT2 and 5-HT3 
receptors by using SSRIs and result in the decrease in levels of dopamine released from the 
Substantia Nigra, leading to serious mental health problems. Patients on SSRIs or TCA for 
a longer period of time or in combination with MAOs become very agitated, having tremor 
and involuntary muscle contraction leading to impaired respiration, increased carbon dioxide 
pressure and hypoxia.
The role of 5-HT receptors is a topic of intense research, so more therapeutic applications may 
be discovered in the future. Concisely, role of serotonin in central nervous system is to con-
trol appetite, vomiting, sleep, mood, hallucinations and pain perception, and peripherally, 
responsible for the contraction of vascular and non-vascular smooth, platelet aggregation, 
increased capillary permeability and modulation of the release of other neurotransmitters.
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